vimarsana.com

Page 4 - புனே சீரம் நிறுவனம் ஆஃப் இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covaxin vs Covishield: Everything you need to know about the two vaccines

Highlights Both the vaccines can be stored at 2-8 degrees Centigrade New Delhi: India is entering its third phase of vaccination program on May 1, under which everyone who is above the age of 18 is eligible to receive COVID-19 vaccine jab. However, to get the vaccine you will have to pre-register yourself on the CoWIN website. The registration begins on April 28. Currently, only Covaxin and Covishield are available in the Indian market and later government approved foreign vaccines like Sputvik V are also expected to be available to the public. Unlike the previous phase of vaccination in India, this time the vaccines will be available both in open market and State hospitals. You will have to pay a price to get

Covaxin vs Covishield: Which vaccine is better, cheaper and you should get

India removes import duty on remdesivir until October Starting May 1, the central government has allowed anyone above the age of 18 to get vaccinated against COVID-19. To do so, the government recommended eligible citizens to use CoWin website for advance booking, which will commence from April 28. Another major change concerning vaccines that takes effect on May 1 is that state governments and private hospitals can independently procure vaccines and administer them at a fixed price per dose. India currently has two vaccines, Covaxin and Covishield, authorised for emergency use. Here s how they compare. Covaxin Covaxin is developed by Bharat Biotech and comes in two doses. As per the second interim analysis, Covaxin has shown efficacy of 78 percent in second and 100 percent efficacy against severe COVID-19 disease. The second dose of Covaxin must be administered within 4-6 weeks of the first dose.

Bharat Biotech s COVAXIN to be sold at Rs 600 to states, Rs 1,200 to private hospitals

: Saturday, April 24, 2021, 10:41 PM IST Bharat Biotech s COVAXIN to be sold at Rs 600 to states, Rs 1,200 to private hospitals It added that for exports, COVAXIN has been pegged at $15-20. In a statement, Bharat Biotech Chairman and Managing Director Krishna M Ella said the company is supplying the vaccine to the central government at Rs 150 per dosage and the government on its part is distributing it free of cost. We would like to state that more than 50 per cent of our capacities have been reserved for central government supplies, Ella said. Recovering the cost is essential in the journey of innovation towards other vaccines such as intranasal Covid-19, Chikungunya, Zika, Cholera and others, he added.

Andhra receives 6 lakh more doses of Covid vaccine

Andhra receives 6 lakh more doses of Covid vaccine ​ By IANS | ​ 2 Views Amaravati, April 17 : Andhra Pradesh on Saturday received 6 lakh additional doses of Covid-19 vaccine. At least five lakh doses of Covishield from Pune s Serum Institute of India (SII) and one lakh Covaxin doses from Hyderabad s Bharat Biotech were received on Saturday, said a health official. This comes a day after Chief Minister Y. S. Jagan Mohan Reddy wrote to Prime Minister Narendra Modi, requesting him for 60 lakh more doses. Reddy promised Modi that if the state receives 60 lakh more doses of Covid vaccine, he will ensure that all the citizens above 45 years are vaccinated for the first dose in the next three weeks.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.